Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
Erratum/Corrigendum, Erratum

Correction: Gliske, “A New Theory of Gender Dysphoria Incorporating the Distress, Social Behavioral, and Body-Ownership Networks”

eNeuro 12 December 2019, 6 (6) ENEURO.0513-19.2019; DOI: https://doi.org/10.1523/ENEURO.0513-19.2019

Correction for “A New Theory of Gender Dysphoria Incorporating the Distress, Social Behavioral, and Body-Ownership Networks,” by Stephen V. Gliske, first published December 2, 2019.

Upon initial publication of the manuscript version of this article, several questions were raised about the validity of the conclusions, particularly the author’s proposed implications for clinical treatment. The editors conducted an independent review of the article in response to these concerns and determined that any clinical or treatment recommendations were, in fact, unsupported by the cited data, and therefore are inappropriate and should be removed. The author agreed with this conclusion and the final version of the article has been edited to remove these speculations, including the removal of the entire “Implications for Clinical Practice” section.

eNeuro’s mission is to advance the understanding of the brain and nervous system through discussion and debate, and to provide a venue for studies and observations that may not present novel findings but that still contribute to greater understanding within the neuroscience community. This article was submitted, underwent double-blind peer review, and published as a Theory/New Concept article and as such, is not based on novel experimental data but serves to question existing dogma. With the unsupported statements related to clinical implications and treatments removed, the editors feel this article serves only to present a perspective through review of the available literature.

As with all eNeuro articles and as part of the journal’s dedication to transparency in peer review, the final version includes a synthesis of the reviewer and editor comments, as well as the author’s response to them on revision.

  • Copyright © 2019 Gliske
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.